BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
PBX1
,
Coagulation
,
Influenza
,
Heart
,
Holistic medicine
,
Lipopolysaccharide
,
rs4950928
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
aPL
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Microglial cell
Plasma cell of spleen
Ileum mucosa
Prostate gland
Colon mucosa
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Mucolipidosis
Myopathy
Movement disorder
Helicobacter pylori gastrointestinal tract infection
Ischemia
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Phenazopyridine
Clopenthixol
Complement C1
Sodium Butyrate
bafilomycin A
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
TIRAP
PNRC2
STK38
GNAQ
Kmt2a
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
The role of sialidase Neu1 in respiratory diseases.
NEU1-A Unique Therapeutic Target for Alzheimer's Disease.
From genomic insights to clinical hope: Targeting NEU1 in IgA nephropathy.
Neuraminidase-1 (NEU1): Biological Roles and Therapeutic Relevance in Human Disease.
Neuraminidase 1 promotes renal fibrosis development in male mice.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
APL-501 or Nivolumab in Combination With APL-101 in Locally Advanced or Metastatic HCC and RCC
Acute Promyelocytic Leukemia 2006 (APL)
Clinical Guidelines for APL Treatment
RWE of 1st Line Treatment With ATO/ATRA for Adult APL
Optimum Induction Therapy of Low-risk APL
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ